Insilico Medicine’s AI-designed Parkinson’s drug cleared for human trials by FDA
The upcoming Phase I trial will test the safety, tolerability, and pharmacokinetics of ISM8969 in healthy volunteers and determine the optimal dosing for future studies
The upcoming Phase I trial will test the safety, tolerability, and pharmacokinetics of ISM8969 in healthy volunteers and determine the optimal dosing for future studies
EMA recommended 30 veterinary medicines for marketing authorisation in 2025
The approval is backed by data showing deep, durable responses and manageable tolerability
The approval introduces a needle-free alternative to injectable GLP-1 therapies
Under the agreement, Insilico could receive up to $32 million in upfront and near-term R&D payments
He noted the enduring relevance of Siddha medicine as “a comprehensive, preventive and sustainable healthcare system in the contemporary world
The accelerated review covers WCK 5222 for multiple critical infections
GSK will make most of its inhaled respiratory portfolio and other products available on a direct purchasing platform, offering savings of up to 66%
StarGuide GX delivers ultra-high sensitivity and high-resolution imaging, enabling fast, confident diagnostics
Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Sapala Organics
Subscribe To Our Newsletter & Stay Updated